You are here: Industry Insights > Biologics

News List

Boehringer to invest €230m in biologics R&D pharmaceutical-technology
June 28, 2018
Boehringer Ingelheim has revealed plans to invest €230m into a new Biologicals Development Center (BDC) set to be constructed at its Research and Development (R&D) site located in Biberach, Germany.
WuXi Biologics Expands Operations contractpharma
May 22, 2018
WuXi Biologics revealed plans to build an integrated biologics development, clinical and commercial manufacturing center in the city of Shijiazhuang, capital of Hebei province in northern China.
Thermo Fisher Invests $50M to Grow Biologics Footprint contractpharma
April 24, 2018
Thermo Fisher Scientific is investing $50 million in its St. Louis, MO site, one of the company's Centers of Excellence for biologic commercial manufacturing.
Eagle Pharma receives New Patent for Biologics biospectrumasia
April 02, 2018
The patent is directed to a technology that allows for the formulation of antibodies at high concentration
Samsung Biologics reinforces biologic manufacturing and development partnership with MSD pharmafile
October 31, 2017
Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the US and Canada, with the signing of a memorandum of understanding
Samsung BioLogics granted FDA approval for its first monoclonal antibody Drug Substance pharmaasia
October 24, 2017
The Samsung Biologics plant is the largest single plant in the world, and this licensing allows it to manufacture Biologics Drug Substances commercially.
AbbVie obtains licence for Turnstone Biologics’ oncolytic viral immunotherapies pharmaceufical-technology
October 13, 2017
Under the deal, AbbVie has obtained an exclusive option to licence up to three of Turnstone's latest oncolytic viral immunotherapies.
Pfizer goes to Court to allow competition for biologics and expand options for patients worldpharmanews
September 21, 2017
To ensure patients and providers have access to important, lower cost biosimilar medicines, Pfizer (NYSE:PFE) has filed suit in the U.S. District Court for the Eastern District of Pennsylvania against Johnson & Johnson (J&J).
Dragonfly Therapeutics Appoints Head of Biologics contractpharma
May 02, 2017
Grinberg brings track record of scientific accomplishments and creativity in protein-based drug development
Japanese pharma companies predict 17 per cent growth in 2017 financialexpress
April 26, 2017
CPhI research shows that the biologics and generics sector are driving growth over the next year

Previous page 1 2 3 4 5 6 7 8 9 Next page